The Asia Bio Partnering Forum program will be developed to highlight the powerful rise of innovation in the Asia life science market
About the Asia Bio Partnering Forum program
While the official event agenda won't be published for a few more weeks, the overview below sets the stage for the insightful conversations that will take place at the event.
Our event agenda includes a high intensity Boot Camp for young start-ups on Day One!
Join our team of experts as they guide you through a packed program of innovative techniques for approaching, engaging and partnering with top investors. Learn how to present your company with energy and confidence!
Opening keynote panel:
Our distinguished opening keynote panel will consist of leading pharma and bio dealmakers, senior executives and investors.
Each with their own unique insight and expertise, they will examine the powerful rise of innovation in China and surrounding Asian markets. Hear China’s strategy for pipelines and partnerships in oncology, infectious diseases, neurology and immunology and discuss the future of R&D in Asia.
Our second panel will continue to focus on the rising appeal of Asian markets. Hear from the latest innovators as they share their ever-expanding capabilities and influence in novel drug discovery.
What does biopharma investment look like in the Asian market in 2023 and beyond? With recent reaction to market changes, learn from leading investors for their insights on emerging areas of innovation and how this impacts the future of development.
Navigating the evolving regulatory landscape has become a huge pain-point for companies. This session will address the specific impacts of regulatory and market access updates on business strategies, partnerships, and investment. Learn from experts on the recent guidelines that affect the Asian markets and what impact this will have on your business.
VC Panel: Investing in a bear market
The panel will examine investment challenges in the current bear market: with investors becoming increasingly cautious and selective, what do early-stage biotechs need to be delivering?
Commercialization for mature products in one of the world’s most complex markets) How will market challenges impact the pace of commercialization and investment in mature products? Hear how to navigate one of the world’s most complex markets, tools on how to enter the market, and what can you do to maintain/stay ahead of competition.